Nonhepatic response to portal glucose delivery in conscious dogs.

The glycemic and hormonal responses and net hepatic and nonhepatic glucose uptakes were quantified in conscious 42-h-fasted dogs during a 180-min infusion of glucose at 10 mg. kg(-1). min(-1) via a peripheral (Pe10, n = 5) or the portal (Po10, n = 6) vein. Arterial plasma insulin concentrations were not different during the glucose infusion in Pe10 and Po10 (37 +/- 6 and 43 +/- 12 microU/ml, respectively), and glucagon concentrations declined similarly throughout the two studies. Arterial blood glucose concentrations during glucose infusion were not different between groups (125 +/- 13 and 120 +/- 6 mg/dl in Pe10 and Po10, respectively). Portal glucose delivery made the hepatic glucose load significantly greater (36 +/- 3 vs. 46 +/- 5 mg. kg(-1). min(-1) in Pe10 vs. Po10, respectively, P < 0.05). Net hepatic glucose uptake (NHGU; 1.1 +/- 0. 4 vs. 3.1 +/- 0.4 mg. kg(-1). min(-1)) and fractional extraction (0. 03 +/- 0.01 vs. 0.07 +/- 0.01) were smaller (P < 0.05) in Pe10 than in Po10. Nonhepatic (primarily muscle) glucose uptake was correspondingly increased in Pe10 compared with Po10 (8.9 +/- 0.4 vs. 6.9 +/- 0.4 mg. kg(-1). min(-1), P < 0.05). Approximately one-half of the difference in NHGU between groups could be accounted for by the difference in hepatic glucose load, with the remainder attributable to the effect of the portal signal itself. Even in the absence of somatostatin and fixed hormone concentrations, the portal signal acts to alter partitioning of a glucose load among the tissues, stimulating NHGU and reducing peripheral glucose uptake.

[1]  D. Wasserman,et al.  A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake. , 1998, American journal of physiology. Endocrinology and metabolism.

[2]  P. Flakoll,et al.  Hepatic glucose disposition during concomitant portal glucose and amino acid infusions in the dog. , 1998, American journal of physiology. Endocrinology and metabolism.

[3]  J. Holst,et al.  Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  J. Olefsky,et al.  Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion , 1997, Diabetes.

[5]  C. Chu,et al.  The Role of Fatty Acids in Mediating the Effects of Peripheral Insulin on Hepatic Glucose Production in the Conscious Dog , 1997, Diabetes.

[6]  W. W. Lautt,et al.  Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. , 1996, The American journal of physiology.

[7]  L. Rossetti,et al.  Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis. , 1996, The American journal of physiology.

[8]  R. Bergman,et al.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. , 1996, The Journal of clinical investigation.

[9]  W. W. Lautt,et al.  Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. , 1996, The American journal of physiology.

[10]  B. Zinman,et al.  Hepatic Glucose Production Is Regulated Both by Direct Hepatic and Extrahepatic Effects of Insulin in Humans , 1996, Diabetes.

[11]  A. Cherrington,et al.  Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. , 1996, The Journal of clinical investigation.

[12]  M. Vranic,et al.  Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs. , 1994, Metabolism: clinical and experimental.

[13]  Y. Minokoshi,et al.  Regulatory mechanism of the ventromedial hypothalamus in enhancing glucose uptake in skeletal muscles , 1994, Brain Research.

[14]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[15]  M. Nauck,et al.  Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. , 1993, The Journal of clinical endocrinology and metabolism.

[16]  R. Adkins,et al.  Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. , 1992, The American journal of physiology.

[17]  A. Cherrington,et al.  Magnitude of Negative Arterial-Portal Glucose Gradient Alters Net Hepatic Glucose Balance in Conscious Dogs , 1991, Diabetes.

[18]  Y. Minokoshi,et al.  Role of the hypothalamus in insulin-independent glucose uptake in peripheral tissues , 1991, Brain Research Bulletin.

[19]  G. Shulman,et al.  Sources of carbon for hepatic glycogen synthesis in the conscious dog. , 1991, The Journal of clinical investigation.

[20]  A. Cherrington,et al.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. , 1991, The Journal of clinical investigation.

[21]  O. McGuinness,et al.  Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. , 1991, The Journal of clinical investigation.

[22]  J. Olefsky,et al.  Direct and Indirect Effects of Insulin to Inhibit Hepatic Glucose Output in Obese Subjects , 1987, Diabetes.

[23]  A. Cherrington,et al.  Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. , 1987, The Journal of clinical investigation.

[24]  R. Eaton,et al.  Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. , 1986, The Journal of clinical endocrinology and metabolism.

[25]  M. Entman,et al.  Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. , 1983, The Journal of clinical investigation.

[26]  Y. le Marchand,et al.  Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice. , 1978, Endocrinology.